Back to search

Switzerland· 67223005

Trimbow 87/5/9 mcg, solution pour inhalation en flacon pressurisé

A formoterol, glycopyrronium bromid und beclometason product containing beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium, registered in Switzerland by Chiesi SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC R03AL09

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTrimbow 87/5/9 mcg, solution pour inh…ATCR03AL09REGISTER NO.67223005PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Formoterol, glycopyrronium bromid und beclometason is registered in 10 of 19 countries.

Countries holding a registration under ATC R03AL09 (formoterol, glycopyrronium bromid und beclometason), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Formoterol, glycopyrronium bromid und beclometason · ATC R03AL09

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium
Manufacturer
Chiesi SA
Country
Switzerland (CH)
ATC code
R03AL09
ATC class
Formoterol, Glycopyrronium bromid und Beclometason
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680672230054
    360 Dos
    CHF 192.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7389bbf-b1f6-4a42-a40c-e16d7850ee4f
GET /v1/drugs/f7389bbf-b1f6-4a42-a40c-e16d7850ee4f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "beclometasoni dipropionas 87 mcg + formoteroli fumaras dihydricus 5 mcg + glycopyrronium 9 mcg",
  "valid_from": "2020-08-01",
  "limitations": "[{\"description\":\"<b>Chronisch obstruktive Lungenerkrankung (COPD)</b><br>\\nFür Patienten mit moderater COPD nach ≥ 1 moderaten Exazerbation pro Jahr trotz einer mindestens 3 Monate dauernder optimierter Therapie unter LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl, welche nicht ausreichend eingestellt sind<br>\\noder<br>\\nfür Patienten mit moderater bis schwerer COPD nach ≥ 2 moderaten Exazerbationen pro Jahr oder ≥ 1 Exazerbation pro Jahr, welche zu einer Hospitalisation geführt hat trotz einer mindestens 3 Monaten dauernden optimierter Therapie unter ICS/LABA oder LABA/LAMA (für LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl), welche nicht ausreichend eingestellt sind<br>\\noder<br>\\nfür Patienten mit COPD, welche bereits mit einer Kombination von LABA/LAMA und ICS oder ICS/LABA und LAMA mit mehreren Inhalatoren therapiert werden.<br>\\n<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2020-08-01\"}]",
  "galenic_form": "Inhal Lös 87µg/5µg/9µg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2020-08-01",
  "self_retention_pct": 10
}

See everything about formoterol, glycopyrronium bromid und beclometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.